Thirty women with urinary incontinence underwent detailed preoperative and postoperative clinical and urodynamic evaluation before and after the pessary test. The urodynamic changes observed with the pessary test (P less than .01) were very similar to those seen after corrective incontinence surgery. The pessary test differentiated patients with bladder instability from those complaining of stress urinary incontinence with a correctable anatomic defect. Pre- and postpessary test voiding urethrocystometry and uroflometry demonstrated absence of urethral obstruction to the free flow of urine. The pessary test is a simple, inexpensive, reliable diagnostic and prognostic tool. It simulates the results of anticipated incontinence surgery and restores continence without causing compression of the urethra as does the Bonney test.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
[Female urinary incontinence - diagnostics and therapies].
Praxis (Bern 1994)
November 2024
Klinik für Gynäkologie, Universitätsspital Zürich, Zürich.
Urinary incontinence is a common complaint of both general practitioners and specialists. An accurate basic diagnosis with a structured medical history and bladder diary, urine analysis, gynaecological examination including pelvic floor assessment and a full bladder cough test can be supplemented by sonography, cystoscopy and urodynamic testing. This will help to differentiate between the different types of urinary incontinence, such as urge incontinence, stress incontinence and overflow incontinence.
View Article and Find Full Text PDFDiscontinuation of pessary therapy within 24 months: can it be predicted?
Arch Gynecol Obstet
December 2024
Department of Obstetrics and Gynaecology, Spaarne Gasthuis, Haarlem, The Netherlands.
Article Synopsis
- Pelvic organ prolapse is a common issue in women, with pessary therapy being a popular non-surgical treatment, but many women (20-60%) stop using it within two years.
- A study conducted in 22 Dutch hospitals aimed to identify patient characteristics that lead to discontinuation of pessary treatment over 24 months, analyzing various patient data.
- Results showed that younger age and self-reported allergies were significant predictors of stopping pessary use, but many allergies were unspecified, indicating that more research is needed to fully understand these factors.*
Barriers and facilitators to self-management of chronic conditions reported by women: a systematic review of qualitative studies.
BMJ Open
November 2024
Saint Mary's Hospital, Manchester Academic Health Science Centre, Manchester, UK.
Objectives: This systematic review aims to identify, appraise and synthesise the findings of published qualitative research exploring the barriers and facilitators to self-management of chronic conditions reported by women.
Design: A systematic literature review and thematic synthesis of qualitative studies.
Data Sources: A search of MEDLINE, CINAHL, Embase and PsycInfo was undertaken using the search terms 'Women', 'Woman' 'Female,' 'Chronic', 'Long-term', 'Disease', 'Illness', 'Condition' 'Health,' 'Self-management,' 'Qualitative,' 'Barrier' and 'Facilitator'.
Cervical pessary is not superior to vaginal progesterone in individuals with a singleton pregnancy and a short cervix: a randomized controlled trial.
Am J Obstet Gynecol
October 2024
Department of Obstetrics and Gynecology, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
Background: For asymptomatic individuals with a singleton pregnancy and a short cervix, vaginal progesterone significantly decreases the risk of PTB and improves perinatal outcomes. Cervical pessary is another option that has been evaluated with inconclusive results. There is, however, a lack of head-to-head comparisons between pessary and vaginal progesterone in this high risk population.
View Article and Find Full Text PDFResults of the RE-DINO multicenter randomized trial on the repeated use of vaginal dinoprostone (Propess®) for labor induction in patients at term.
Am J Obstet Gynecol MFM
November 2024
Department of Gynecology and Obstetrics, Brive Hospital Center, Brive, France (Siegerth, Cantaloube, and Hessas).
Article Synopsis
- - Labor induction in France often involves using intravaginal dinoprostone (Propess®), but there's debate on whether to repeat this or switch to oxytocin if labor doesn’t start within 24 hours.
- - The study aimed to compare the effectiveness of a second Propess® placement followed by oxytocin versus direct oxytocin in increasing vaginal delivery rates among pregnant women who didn’t respond to the first Propess®.
- - Results showed no significant difference in vaginal delivery rates between the two methods (76.3% for the second Propess® vs. 73.8% for oxytocin), but more cesarean sections occurred in the Propess® group due to dilation issues.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!